Growth Disorders
|
group |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Hemolysis (disorder)
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pre-Eclampsia
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
166
|
14
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Rhabdomyolysis
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
36
|
15
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Retinal ischemia
|
disease |
Eye Diseases
|
Pathologic Function
|
7
|
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Contact hypersensitivity
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Extravascular Hemolysis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stenosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
19
|
1
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Brain Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
30
|
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Delayed Graft Function
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Heart Decompensation
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
113
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cerebral Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
122
|
78
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Growth delay
|
phenotype |
|
Pathologic Function
|
244
|
40
|
0.100 |
None |
|
0 |
|
|
|
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.500 |
None |
1.000 |
2 |
|
2005 |
2012 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.982 |
56 |
|
1999 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.896 |
48 |
|
2000 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.900 |
40 |
|
2000 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.955 |
22 |
|
2003 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
18 |
|
2004 |
2020 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
17 |
|
2007 |
2020 |